Ani Pharmaceuticals Stock Price on December 10, 2024
| ANIP Stock | USD 56.04 0.52 0.92% |
Below is the normalized historical share price chart for ANI Pharmaceuticals extending back to July 24, 2001. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ANI Pharmaceuticals stands at 56.04, as last reported on the 13th of December 2024, with the highest price reaching 56.04 and the lowest price hitting 56.04 during the day.
If you're considering investing in ANI Stock, it is important to understand the factors that can impact its price. Currently, ANI Pharmaceuticals is very steady. ANI Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0155, which signifies that the company had a 0.0155% return per unit of return volatility over the last 3 months. We have found twenty-eight technical indicators for ANI Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm ANI Pharmaceuticals' Risk Adjusted Performance of 0.0343, semi deviation of 2.22, and Mean Deviation of 1.89 to double-check if the risk estimate we provide is consistent with the expected return of 0.0346%.
At this time, ANI Pharmaceuticals' Total Stockholder Equity is relatively stable compared to the past year. As of 12/13/2024, Common Stock Shares Outstanding is likely to grow to about 19.1 M, though Treasury Stock is likely to grow to (618.2 K). . At this time, ANI Pharmaceuticals' Price Earnings Ratio is relatively stable compared to the past year. As of 12/13/2024, Price To Operating Cash Flows Ratio is likely to grow to 9.30, though Price Earnings To Growth Ratio is likely to grow to (0.38). ANI Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of May 2000 | 200 Day MA 62.1628 | 50 Day MA 58.0058 | Beta 0.71 |
ANI |
Sharpe Ratio = 0.0155
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ANIP |
Estimated Market Risk
| 2.23 actual daily | 19 81% of assets are more volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average ANI Pharmaceuticals is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ANI Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 3.0635 | Enterprise Value Ebitda 24.8101 | Price Sales 2.1402 | Shares Float 15.9 M | Wall Street Target Price 78.6667 |
Related Headline
Alkermes Plc Headline on 10th of December 2024
Alkermes director Cato Laurencin sells 85,708 in stock by investing.com
Alkermes director Cato Laurencin sells 85,708 in stock
ANI Pharmaceuticals Valuation on December 10, 2024
It is possible to determine the worth of ANI Pharmaceuticals on a given historical date. On December 10, 2024 ANI was worth 58.41 at the beginning of the trading date compared to the closed value of 59.16. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ANI Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find ANI Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ANI Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ANI Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 57.22 | 58.80 | 56.33 | 58.03 | 276,116 | |
12/10/2024 | 58.41 | 59.34 | 57.25 | 59.16 | 243,217 |
| 59.97 | 60.91 | 58.48 | 59.17 | 254,431 |
| Backtest ANI Pharmaceuticals | | | ANI Pharmaceuticals History | | | ANI Pharmaceuticals Valuation | Previous | Next |
ANI Pharmaceuticals Trading Date Momentum on December 10, 2024
| On December 11 2024 ANI Pharmaceuticals was traded for 59.17 at the closing time. The top price for the day was 60.91 and the lowest listed price was 58.48 . The trading volume for the day was 254.4 K. The trading history from December 11, 2024 was a factor to the next trading day price gain. The overall trading delta against the next closing price was 0.02% . The overall trading delta against the current closing price is 4.39% . |
ANI Pharmaceuticals Fundamentals Correlations and Trends
By evaluating ANI Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ANI Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ANI financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ANI Pharmaceuticals Stock history
ANI Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ANI is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ANI Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ANI Pharmaceuticals stock prices may prove useful in developing a viable investing in ANI Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 18.2 M | 19.1 M | |
| Net Loss | -44.6 M | -42.3 M |
ANI Pharmaceuticals Quarterly Net Working Capital |
|
ANI Pharmaceuticals Stock Technical Analysis
ANI Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
ANI Pharmaceuticals Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
ANI Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ANI Pharmaceuticals December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how ANI Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ANI Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying ANI Pharmaceuticals stock market strength indicators, traders can identify ANI Pharmaceuticals entry and exit signals to maximize returns
ANI Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ANI Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of ANI Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ANI to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0343 | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.25) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0604 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for ANI Stock Analysis
When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.